Post Categories
QPS Celebrating Sustained Growth in Asia
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 –…
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 –…
Conference Report: EAACI Annual Conference in Lisbon, Portugal on June 1 – 5, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS Netherlands, and EAACI Asthma Section Chair 2017-2019, lectured…
Conference Report: EAACI Annual Conference in Lisbon, Portugal on June 1 – 5, 2019
June 17, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS Netherlands, and EAACI Asthma Section Chair 2017-2019, lectured…
Power Women in Business Development at QPS Netherlands
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen,…
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen,…
Inflammatory Disease Models and Biomarkers
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be…
Inflammatory Disease Models and Biomarkers
June 10, 2019
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be…
Accelerating Pharmaceutical Breakthroughs for CNS Disorders
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues…
Accelerating Pharmaceutical Breakthroughs for CNS Disorders
June 5, 2019
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues…
Skin Biopsy: A Complex Model Exploring Gene Expression
The heterogeneous presentation of clinical cases and the complex requirements by health authorities and care management contribute to making the development of innovative treatment…
Skin Biopsy: A Complex Model Exploring Gene Expression
May 9, 2019
The heterogeneous presentation of clinical cases and the complex requirements by health authorities and care management contribute to making the development of innovative treatment…
QPS: Young at Heart
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology….
QPS: Young at Heart
May 9, 2019
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology….
Meet QPS at the EAACI in Lisbon
Professor Zuzana Diamant, EAACI Asthma Section Chair (2017-2019), will chair and lecture at the EAACI (European Academy of Allergy and Clinical Immunology) symposium in…
Meet QPS at the EAACI in Lisbon
May 9, 2019
Professor Zuzana Diamant, EAACI Asthma Section Chair (2017-2019), will chair and lecture at the EAACI (European Academy of Allergy and Clinical Immunology) symposium in…
Meet QPS at the ATS in Dallas
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
Meet QPS at the ATS in Dallas
May 9, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
DDI Studies: The Final Frontier?
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
DDI Studies: The Final Frontier?
May 9, 2019
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
Challenging the Inhaled Allergen Challenge
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
Challenging the Inhaled Allergen Challenge
May 9, 2019
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
QPS has a Strong Competency in Alzheimer Research
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
Cancer Cure? 10-Year Leukemia Remission Reported with Personalized T-Cell Therapy
Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia…
Cancer Cure? 10-Year Leukemia Remission Reported with Personalized T-Cell Therapy
February 21, 2022
Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia…
Groundbreaking Pig Heart Transplant Saves Patient’s Life
Xenotransplantation, or the transplantation of non-human tissues or organs into a human recipient, has long been a controversial possibility in the medical field. After…
Groundbreaking Pig Heart Transplant Saves Patient’s Life
February 16, 2022
Xenotransplantation, or the transplantation of non-human tissues or organs into a human recipient, has long been a controversial possibility in the medical field. After…
Is Immune System Memory Good or Bad News for COVID-19?
The COVID-19 pandemic has prompted a boom in immunology research. One research question is whether a previous infection with a common-cold coronavirus helps the…
Is Immune System Memory Good or Bad News for COVID-19?
February 14, 2022
The COVID-19 pandemic has prompted a boom in immunology research. One research question is whether a previous infection with a common-cold coronavirus helps the…
A New Proteo-Genomic Map Shows How Genes Connect to a Variety of Diseases
Like the infamous Marauder’s Map in the Harry Potter novels, which revealed all the secrets of Hogwarts Castle, a recently published proteo-genomic map uncovers…
A New Proteo-Genomic Map Shows How Genes Connect to a Variety of Diseases
February 7, 2022
Like the infamous Marauder’s Map in the Harry Potter novels, which revealed all the secrets of Hogwarts Castle, a recently published proteo-genomic map uncovers…
Sea Squirts and Missing Genes
It might seem odd to use a tiny sea creature to explore human genetics. However, as recently reported on Shamini Bundell’s Nature Podcast, marine…
Sea Squirts and Missing Genes
February 2, 2022
It might seem odd to use a tiny sea creature to explore human genetics. However, as recently reported on Shamini Bundell’s Nature Podcast, marine…
Approved: First Drug to Boost Growth in Children With Dwarfism
The first drug to counter the genetic mutation that causes achondroplasia, the most common form of dwarfism, received accelerated FDA approval in November. BioMarin…
Approved: First Drug to Boost Growth in Children With Dwarfism
January 31, 2022
The first drug to counter the genetic mutation that causes achondroplasia, the most common form of dwarfism, received accelerated FDA approval in November. BioMarin…
At QPS We Believe In Developing Close And Long-Lasting Relationships With Our Clients On The Basis Of Trust And Mutual Respect. This mutual trust,…
Introduction RNA based drugs are a promising new class of therapeutics with tremendous potential for treating a wide range of diseases. There are various…
About Messenger Ribonucleic Acid (mRNA) Current mRNA (messenger ribonucleic acid) research has rapidly driven the discovery and production of this new therapeutic. Modified mRNAs…
NEWARK, Delaware, January 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
NEWARK, Delaware, Dec. 14, 2023/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
SPRINGFIELD, Missouri, Dec. 4, 2023/BUSINESS WIRE/ — QPS Holdings, LLC, a global contract research organization, has expanded operations in Springfield, Missouri. The new facilities…